Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6126
CALL
Genesco
GCO
$425M
| $7K | ﹤0.01% |
+100
| New | +$6.86K |
|
6127
HCI Group
HCI
$2.23B
| $7K | ﹤0.01% |
164
-101
| -38% | -$4.53K |
|
6128
Insteel Industries
IIIN
$593M
| $7K | ﹤0.01% |
353
-195
| -36% | -$3.98K |
|
6129
Immunic
IMUX
$190M
| $7K | ﹤0.01% |
+1
| New | +$9.54K |
|
6130
PUT
Keurig Dr Pepper
KDP
$42.3B
| $7K | ﹤0.01% |
100
| – | – |
|
6131
State Street SPDR S&P Insurance ETF
KIE
$649M
| $7K | ﹤0.01% |
+300
| New | +$6.83K |
|
6132
Lennar Class B
LEN.B
$19.4B
| $7K | ﹤0.01% |
+165
| New | +$6.03K |
|
6133
Mercantile Bank Corp
MBWM
$1.04B
| $7K | ﹤0.01% |
323
-183
| -36% | -$3.71K |
|
6134
Marcus Corp
MCS
$897M
| $7K | ﹤0.01% |
351
-189
| -35% | -$3.78K |
|
6135
Middlesex Water
MSEX
$1.08B
| $7K | ﹤0.01% |
308
-171
| -36% | -$3.84K |
|
6136
NVE Corp
NVEC
$562M
| $7K | ﹤0.01% |
92
-50
| -35% | -$3.54K |
|
6137
Onto Innovation
ONTO
$12.9B
| $7K | ﹤0.01% |
460
-260
| -36% | -$4.06K |
|
6138
Preferred Bank
PFBC
$1.24B
| $7K | ﹤0.01% |
223
-727
| -77% | -$20.8K |
|
6139
Park Aerospace
PKE
$737M
| $7K | ﹤0.01% |
389
-281
| -42% | -$6K |
|
6140
Plug Power
PLUG
$2.87B
| $7K | ﹤0.01% |
3,316
-1,725
| -34% | -$4.51K |
|
6141
Ribbon Communications
RBBN
$377M
| $7K | ﹤0.01% |
1,039
-177,113
| -99% | -$1.39M |
|
|
SOL
6142
PUT
DELISTED
Emeren Group
SOL
| $7K | ﹤0.01% |
1,480
-3,300
| -69% | -$26K |
|
|
SRDX
6143
DELISTED
Surmodics
SRDX
| $7K | ﹤0.01% |
313
-136
| -30% | -$3.41K |
|
6144
Sasol
SSL
$7.5B
| $7K | ﹤0.01% |
193
+83
| +75% | +$3.06K |
|
6145
Theravance Biopharma
TBPH
$874M
| $7K | ﹤0.01% |
571
-567
| -50% | -$8.79K |
|
6146
WPP
WPP
$4.36B
| $7K | ﹤0.01% |
64
-7,200
| -99% | -$846K |
|
|
HTB
6147
HomeTrust Bancshares
HTB
$860M
| $7K | ﹤0.01% |
388
-234
| -38% | -$3.73K |
|
|
VTNR
6148
DELISTED
Vertex Energy, Inc
VTNR
| $7K | ﹤0.01% |
3,301
+2,893
| +709% | +$7.79K |
|
|
TAST
6149
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $7K | ﹤0.01% |
679
-4,387
| -87% | -$42.4K |
|
|
ARAV
6150
DELISTED
Aravive, Inc. Common Stock
ARAV
| $7K | ﹤0.01% |
82
-23
| -22% | -$2.33K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.